Navigation Links
Dr. Roger Reeves, 2012 Sisley-Jérôme Lejeune Prize Winner, Significantly Advances Understanding of the Biology of Down Syndrome Leading to New Avenues of Research
Date:9/12/2013

Philadelphia, PA (PRWEB) September 12, 2013

The Jérôme Lejeune Foundation welcomes the results obtained by Professor Roger Reeves, recipient of the 2012 Sisley-Jérôme Lejeune Prize, recently published in the journal, Science Translational Medicine (Sept.4, 2013). This work marks another significant development in understanding intellectual disability, particularly Down syndrome, and pathways to the development of potential therapies to improve the lives of those affected by them. The Jérôme Lejeune Foundation continues its mission of supporting research into genetic intellectual disability, encouraged by the rapid pace of progress made by researchers in recent months.

In receiving the Sisley -Jérôme Lejeune award last November at the Museum of Medicine in Paris, Dr. Reeves announced to those present that his contributions were not completed, and that the best was yet to come. With his research team at Johns Hopkins University, and in partnership with researchers at the National Institutes of Health, he has announced the identification of a substance capable of normalizing the development of the cerebellum in a mouse model of Down syndrome with just a single injection. The result is improved memory and learning.

Dr. William Mobley, Chair of the Department of Neurosciences at the University of California, San Diego, and Chair of the Jérôme Lejeune Foundation USA Scientific Advisory Board commented that this is "Interesting and important work raising the possibility that Shh signaling deficits feature in the cerebellar and hippocampal abnormalities in a mouse model of DS”. Dr. Mobley believes that “The work will stimulate new studies as to how this signaling pathway is impacted”, and further commented that, “While the authors do not envision the agent they used in mice would be appropriate for clinical studies in humans, they point to the possibility that similar pathways may be therapeutically targeted in people with Down syndrome."

Dr. Reeves’ announcement follows other recent developments in this area of research. In July, Dr. Jeanne Lawrence of the University of Massachusetts announced that her lab had silenced the extra 21st chromosome in human induced pluripotent stem cells by introducing the XIST gene. In November a team of researchers at the University of Washington announced similar news of a technique to remove the extra 21st chromosome in their lab. Also, on the clinical front, in July, a Japanese pharmaceutical company launched a clinical trial to test a drug usually used for Alzheimer's disease for the benefit of people living with Down syndrome, and even more recently, a phase 2a study has just begun on a drug developed by the Irish pharmaceutical company, Elan, which is hoped will improve everyday cognitive function of individuals with Down syndrome.

The Sisley - Jérôme Lejeune Prize has been awarded to leading researchers since 2010. It is intended to acknowledge significant contributions and personal commitment to improving the lives of those living with genetic intellectual disabilities, and to bring notoriety and encouragement to them in their work. The first prize was given to Dr. Mara Dierssen of the Center for Genomic Regulation in Barcelona in 2010, Since then, American researchers have been the recipients. Dr. Wiliam Mobley from the University of California, San Diego in 2011 and Dr. Roger Reeves in 2012 . The fourth edition of the Sisley -Jérôme Lejeune Prize will be awarded on October 17 in Paris to two exceptional senior researchers, one French and the other American. Three young talented researchers will also be acknowledged.

ABOUT THE JEROME LEJEUNE FOUNDATION
The Jérôme Lejeune Foundation is the world’s largest private funder of research into Down syndrome and other genetic intellectual disabilities providing approximately $5 million annually to fund it’s own research program, clinical trials, and other researchers working in countries throughout the world to improve the lives of those living with genetic intellectual disabilities. Founded in Paris by the Lejeune family after the death of Jérôme Lejeune, the geneticist who discovered the genetic cause of Down syndrome, the Foundation’s mission is directed toward research, care and advocacy for those with genetic intellectual disabilities. The Foundation has offices in Paris and Philadelphia.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11103404.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Dentist in Arlington, VA, Dr. Michael Rogers Launches New Website
2. InnovaNet Group Expands West Coast Presence with the Addition of Roger Barata and Steve Kaplan
3. MentorMate Appoints Roger Ferguson as its Vice President of Professional Services
4. Jackson, MS Periodontist, Dr. Roger Parkes Brings Gum Disease Patients the FDA-cleared Laser Gum Disease Treatment
5. Fitness Franchise Fit Body Boot Camp Opens First Saskatchewan Location and Announces Lloydminster Personal Trainer Michele Rogers as Owner
6. Anne Miner, Hosts New Rogers Community TV series "Women of Courage"
7. Dr. Roger D. Weiss earns Hazeldens Dan Anderson Research Award
8. Nobel laureate Roger Tsien, Ph.D., keynotes Cedars-Sinai nanomedicine conference March 15, 16
9. Rogers Athletic Company Donates Fitness Equipment to Eagle Village
10. The Jerome Lejeune Foundation, USA Joins Advocacy Organizations Worldwide to Say: Down Syndrome - So What!
11. U.S. Army Veteran and Caregiver for Seniors is Grand Prize Winner of Caring Champion Contest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... May 26, 2017 , ... Water damage to the flooring of several ... had left education officials with a number of critical issues to address before students ... to be accomplished with little or no disruption to class schedules. Second, the project ...
(Date:5/24/2017)... ... 24, 2017 , ... In modern research, success depends greatly ... for research and understanding the basic principles that were designed to drive that ... in stereo microscopy for brightfield and fluorescence typically used in laboratories working on ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... Altec ... its participation in nVerge 2017 – a one-day technology conference in San Diego, CA. ... management solution, which allows users to fully utilize and enhance their Sage ERP solutions ...
(Date:5/24/2017)... ... May 24, 2017 , ... Drs. Nicholas Rallis and ... now spent 10 years as clinical instructors for the reputable Full Mouth Rehabilitation ... Through the program, private practitioners receive cutting-edge clinical training and learn how to ...
(Date:5/24/2017)... OH (PRWEB) , ... May 24, 2017 , ... Patients ... in Cortland, OH, can now meet with Dr. Joseph Bedich for a consultation, with ... while simultaneously improving their oral health and functionality. , Dr. Bedich offers ...
Breaking Medicine News(10 mins):
(Date:5/12/2017)...  The China and Canada joint tech ... water, energy and detergent, and features a powerful disinfection process. ... washing machine that washes and sanitizes women,s panties or babies, cloth ... ... does not require an external water inlet. ...
(Date:5/10/2017)... Mass., May 10, 2017 Hologic, Inc. (Nasdaq: ... results for the fiscal second quarter ended April 1, ... of $1.84 increased 666.7% compared to the prior year ... resulted in a significant gain, while non-GAAP diluted EPS ... 3.2%, or 3.8% in constant currency terms.  Excluding the ...
(Date:5/10/2017)... , May 10, 2017  The Corporate ... or employees of sleep therapy clinics to call ... sleep therapy clinic is involved in a substantial ... interested in hearing from an employee of a ... in a kickback scheme to provide medical practice groups ...
Breaking Medicine Technology: